STRATA Skin Sciences to Participate in Upcoming Investor Conferences

Rhea-AI Summary

STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced its participation in two upcoming investor conferences. Management will present at the H.C Wainwright 23rd Annual Global Investment Conference on September 13 at 7:00 am ET, and at the Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit on September 20 at 3:45 pm ET. Webcasts of both presentations will be accessible on the Company's website. STRATA specializes in dermatology technology, offering products like the XTRAC and Pharos lasers for treating conditions such as psoriasis and vitiligo, impacting over 31 million patients in the U.S.

HORSHAM, Pa., Sept. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in two upcoming investor conferences.

STRATA Skin Science’s management is scheduled to present at the H.C Wainwright 23^rd Annual Global Investment Conference on Monday, September 13^th at 7:00 am Eastern Time. Interested parties may access a live and archived webcast of the presentation on the investor section of the Company’s website at www.strataskinsciences.com.

STRATA Skin Science’s management is scheduled to present at the Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit on Monday, September 20, at 3:45 pm Eastern Time. Interested parties may access a live and archived webcast of the presentation on the investor section of the Company’s website at www.strataskinsciences.com.

About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® and now Pharos® excimer lasers and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions.

The Company’s proprietary XTRAC and recently acquired Pharos excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone.

STRATA’s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.

Investor Contacts:

Leigh Salvo

(415) 937-5404

ir@strataskin.com

FAQ

When is STRATA Skin Sciences' presentation at the H.C Wainwright Conference?

STRATA Skin Sciences will present at the H.C Wainwright 23rd Annual Global Investment Conference on September 13 at 7:00 am Eastern Time.

What date will STRATA Skin Sciences present at the Oppenheimer Summit?

The presentation at the Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit is scheduled for September 20 at 3:45 pm Eastern Time.

How can I access the webcasts of STRATA Skin Sciences' presentations?

The webcasts of STRATA Skin Sciences' presentations will be available on the investor section of their website.

What products does STRATA Skin Sciences offer for dermatologic conditions?

STRATA Skin Sciences offers the XTRAC and Pharos excimer lasers for treating conditions like psoriasis, vitiligo, and eczema.

How many patients in the U.S. are impacted by the conditions treated by STRATA's products?

Over 31 million patients in the United States are impacted by conditions treated by STRATA's products.